,X,FilingDate,TradeDate,Ticker,InsiderName,Title,TradeType,Price,Qty,Owned,delta_Own,Value,1d,1w,1m,6m,ticker
0,D,2022-02-24 16:09:57,2022-02-22,AXGN,Donovan Michael Patrick,VP Operations,M - OptEx,5.21,15000,57453,+35%,78150.0,,,,,AXGN
1,,2022-02-17 16:14:02,2022-02-15,AXGN,Zaderej Karen L.,CEO,A - Grant,0.0,13978,940383,+2%,0.0,,,,,AXGN
2,,2022-02-17 16:12:26,2022-02-15,AXGN,Sandberg Eric,Chief Commercial Officer,A - Grant,0.0,2531,8310,+44%,0.0,,,,,AXGN
3,,2022-02-17 16:12:26,2022-02-15,AXGN,Sandberg Eric,Chief Commercial Officer,F - Tax,8.42,-762,8310,-8%,-6416.0,,,,,AXGN
4,,2022-02-17 16:11:26,2022-02-15,AXGN,Scopelianos Angelo,"Chief R, D Officer",A - Grant,0.0,1325,11950,+12%,0.0,,,,,AXGN
5,,2022-02-17 16:11:26,2022-02-15,AXGN,Scopelianos Angelo,"Chief R, D Officer",F - Tax,8.42,-400,11950,-3%,-3368.0,,,,,AXGN
6,,2022-02-17 16:10:15,2022-02-15,AXGN,Martinez Maria D.,CHRO,A - Grant,0.0,1325,6656,+25%,0.0,,,,,AXGN
7,,2022-02-17 16:10:15,2022-02-15,AXGN,Martinez Maria D.,CHRO,F - Tax,8.42,-400,6656,-6%,-3368.0,,,,,AXGN
8,,2022-02-17 16:09:19,2022-02-15,AXGN,Mariani Peter J,"EVP, CFO",A - Grant,0.0,3157,26353,+14%,0.0,,,,,AXGN
9,,2022-02-17 16:09:19,2022-02-15,AXGN,Mariani Peter J,"EVP, CFO",F - Tax,8.42,-950,26353,-3%,-7999.0,,,,,AXGN
10,,2022-02-17 16:08:18,2022-02-15,AXGN,Friedman Mark Louis,"VP Regulatory Affairs, Policy",A - Grant,0.0,1181,19845,+6%,0.0,,,,,AXGN
11,,2022-02-17 16:08:18,2022-02-15,AXGN,Friedman Mark Louis,"VP Regulatory Affairs, Policy",F - Tax,8.42,-357,19845,-2%,-3006.0,,,,,AXGN
12,,2022-02-17 16:06:59,2022-02-15,AXGN,Donovan Michael Patrick,VP Operations,A - Grant,0.0,675,42453,+2%,0.0,,,,,AXGN
13,,2022-02-17 16:06:59,2022-02-15,AXGN,Donovan Michael Patrick,VP Operations,F - Tax,8.42,-205,42453,0%,-1726.0,,,,,AXGN
14,,2022-02-17 16:05:31,2022-02-15,AXGN,Devinney Erick Wayne,VP Peripheral Nerve Science,A - Grant,0.0,1181,88075,+1%,0.0,,,,,AXGN
15,,2022-02-17 16:05:31,2022-02-15,AXGN,Devinney Erick Wayne,VP Peripheral Nerve Science,F - Tax,8.42,-357,88075,0%,-3006.0,,,,,AXGN
16,,2022-02-17 16:03:54,2022-02-15,AXGN,Billet Isabelle,"Chief Strategy, BD Officer",A - Grant,0.0,1325,15716,+9%,0.0,,,,,AXGN
17,,2022-02-17 16:03:54,2022-02-15,AXGN,Billet Isabelle,"Chief Strategy, BD Officer",F - Tax,8.42,-447,15716,-3%,-3764.0,,,,,AXGN
18,D,2021-12-29 16:33:23,2021-12-27,AXGN,Zaderej Karen L.,CEO,F - Tax,9.74,-1752,925677,0%,-17064.0,,,,,AXGN
19,D,2021-12-29 16:33:23,2021-12-27,AXGN,Zaderej Karen L.,CEO,M - OptEx,0.0,4400,925677,0%,0.0,,,,,AXGN
20,D,2021-12-29 16:31:01,2021-12-27,AXGN,Scopelianos Angelo,"Chief R, D Officer",F - Tax,9.74,-286,10984,-3%,-2786.0,,,,,AXGN
21,D,2021-12-29 16:31:01,2021-12-27,AXGN,Scopelianos Angelo,"Chief R, D Officer",M - OptEx,0.0,1150,10984,+12%,0.0,,,,,AXGN
22,D,2021-12-29 16:30:02,2021-12-27,AXGN,Martinez Maria D.,CHRO,F - Tax,9.74,-286,5731,-5%,-2786.0,,,,,AXGN
23,D,2021-12-29 16:30:02,2021-12-27,AXGN,Martinez Maria D.,CHRO,M - OptEx,0.0,1150,5731,+25%,0.0,,,,,AXGN
24,D,2021-12-29 16:28:59,2021-12-27,AXGN,Mariani Peter J,"EVP, CFO",F - Tax,9.74,-648,24146,-3%,-6312.0,,,,,AXGN
25,D,2021-12-29 16:28:59,2021-12-27,AXGN,Mariani Peter J,"EVP, CFO",M - OptEx,0.0,2625,24146,+12%,0.0,,,,,AXGN
26,D,2021-12-29 16:23:24,2021-12-27,AXGN,Friedman Mark Louis,"VP Regulatory Affairs, Policy",F - Tax,9.74,-286,17452,-2%,-2786.0,,,,,AXGN
27,D,2021-12-29 16:23:24,2021-12-27,AXGN,Friedman Mark Louis,"VP Regulatory Affairs, Policy",M - OptEx,0.0,1150,17452,+7%,0.0,,,,,AXGN
28,D,2021-12-29 16:21:42,2021-12-27,AXGN,Donovan Michael Patrick,VP Operations,F - Tax,9.74,-286,41983,-1%,-2786.0,,,,,AXGN
29,D,2021-12-29 16:21:42,2021-12-27,AXGN,Donovan Michael Patrick,VP Operations,M - OptEx,0.0,1150,41983,+3%,0.0,,,,,AXGN
30,D,2021-12-29 16:17:39,2021-12-27,AXGN,Devinney Erick Wayne,VP Peripheral Nerve Science,F - Tax,9.74,-187,87249,0%,-1821.0,,,,,AXGN
31,D,2021-12-29 16:17:39,2021-12-27,AXGN,Devinney Erick Wayne,VP Peripheral Nerve Science,M - OptEx,0.0,750,87249,+1%,0.0,,,,,AXGN
32,D,2021-12-29 16:15:29,2021-12-27,AXGN,Billet Isabelle,"Chief Strategy, BD Officer",F - Tax,9.74,-326,14184,-2%,-3175.0,,,,,AXGN
33,D,2021-12-29 16:15:29,2021-12-27,AXGN,Billet Isabelle,"Chief Strategy, BD Officer",M - OptEx,0.0,1150,14184,+9%,0.0,,,,,AXGN
34,D,2021-12-22 16:09:09,2021-12-20,AXGN,Zaderej Karen L.,CEO,F - Tax,9.24,-1243,923029,0%,-11485.0,,,,,AXGN
35,D,2021-12-22 16:09:09,2021-12-20,AXGN,Zaderej Karen L.,CEO,M - OptEx,0.0,3125,923029,0%,0.0,,,,,AXGN
36,D,2021-12-22 16:07:50,2021-12-20,AXGN,Mariani Peter J,"EVP, CFO",F - Tax,9.24,-757,22169,-3%,-6995.0,,,,,AXGN
37,D,2021-12-22 16:07:50,2021-12-20,AXGN,Mariani Peter J,"EVP, CFO",M - OptEx,0.0,1900,22169,+9%,0.0,,,,,AXGN
38,D,2021-12-22 16:06:19,2021-12-20,AXGN,Friedman Mark Louis,"VP Regulatory Affairs, Policy",F - Tax,9.24,-95,16588,-1%,-878.0,,,,,AXGN
39,D,2021-12-22 16:06:19,2021-12-20,AXGN,Friedman Mark Louis,"VP Regulatory Affairs, Policy",M - OptEx,0.0,375,16588,+2%,0.0,,,,,AXGN
40,D,2021-12-22 16:04:44,2021-12-20,AXGN,Donovan Michael Patrick,VP Operations,F - Tax,9.24,-95,41119,0%,-878.0,,,,,AXGN
41,D,2021-12-22 16:04:44,2021-12-20,AXGN,Donovan Michael Patrick,VP Operations,M - OptEx,0.0,375,41119,+1%,0.0,,,,,AXGN
42,D,2021-12-22 16:03:21,2021-12-20,AXGN,Devinney Erick Wayne,VP Peripheral Nerve Science,F - Tax,9.24,-144,86686,0%,-1331.0,,,,,AXGN
43,D,2021-12-22 16:03:21,2021-12-20,AXGN,Devinney Erick Wayne,VP Peripheral Nerve Science,M - OptEx,0.0,575,86686,+1%,0.0,,,,,AXGN
44,D,2021-12-17 16:02:34,2021-12-15,AXGN,Devinney Erick Wayne,VP Peripheral Nerve Science,F - Tax,8.8,-4171,86255,-5%,-36705.0,,,,,AXGN
45,D,2021-12-17 16:02:34,2021-12-15,AXGN,Devinney Erick Wayne,VP Peripheral Nerve Science,M - OptEx,3.67,10000,86255,+13%,36700.0,,,,,AXGN
46,D,2021-11-29 16:09:37,2021-11-24,AXGN,Zaderej Karen L.,CEO,M - OptEx,8.95,52375,921147,+6%,468756.0,,,,,AXGN
47,DM,2021-08-16 16:10:25,2021-08-12,AXGN,Zaderej Karen L.,CEO,M - OptEx,3.88,54754,868772,+7%,212668.0,,,,,AXGN
48,D,2021-08-10 16:52:09,2021-08-10,AXGN,Zaderej Karen L.,CEO,M - OptEx,5.09,75000,814018,+10%,381750.0,,,,,AXGN
49,D,2021-08-10 16:52:09,2021-08-06,AXGN,Zaderej Karen L.,CEO,S - Sale+OE,18.47,-41000,814018,-5%,-757194.0,,,,,AXGN
50,,2021-07-23 16:06:32,2021-07-21,AXGN,Donovan Michael Patrick,VP Operations,S - Sale,20.04,-1935,40839,-5%,-38777.0,,,,,AXGN
51,,2021-07-21 16:16:16,2021-07-19,AXGN,Devinney Erick Wayne,VP Peripheral Nerve Science,A - Grant,0.0,1580,80426,+2%,0.0,,,,,AXGN
52,,2021-07-21 16:16:16,2021-07-20,AXGN,Devinney Erick Wayne,VP Peripheral Nerve Science,F - Tax,19.2,-392,80426,0%,-7526.0,,,,,AXGN
53,,2021-07-21 16:15:54,2021-07-19,AXGN,Donovan Michael Patrick,VP Operations,A - Grant,0.0,2572,42774,+6%,0.0,,,,,AXGN
54,,2021-07-21 16:15:54,2021-07-20,AXGN,Donovan Michael Patrick,VP Operations,F - Tax,19.2,-637,42774,-1%,-12230.0,,,,,AXGN
55,,2021-07-21 16:15:14,2021-07-19,AXGN,Zaderej Karen L.,CEO,A - Grant,0.0,22077,780018,+3%,0.0,,,,,AXGN
56,,2021-07-21 16:15:14,2021-07-20,AXGN,Zaderej Karen L.,CEO,F - Tax,19.2,-8812,780018,-1%,-169190.0,,,,,AXGN
57,,2021-07-21 16:14:38,2021-07-19,AXGN,Sandberg Eric,Chief Commercial Officer,A - Grant,0.0,4408,6541,+207%,0.0,,,,,AXGN
58,,2021-07-21 16:14:38,2021-07-20,AXGN,Sandberg Eric,Chief Commercial Officer,F - Tax,19.2,-1090,6541,-14%,-20928.0,,,,,AXGN
59,,2021-07-21 16:14:18,2021-07-19,AXGN,Scopelianos Angelo,"Chief R, D Officer",A - Grant,0.0,2572,10120,+34%,0.0,,,,,AXGN
60,,2021-07-21 16:14:18,2021-07-20,AXGN,Scopelianos Angelo,"Chief R, D Officer",F - Tax,19.2,-637,10120,-6%,-12230.0,,,,,AXGN
61,,2021-07-21 16:14:00,2021-07-19,AXGN,Mariani Peter J,"EVP, CFO",A - Grant,0.0,3710,21026,+21%,0.0,,,,,AXGN
62,,2021-07-21 16:14:00,2021-07-20,AXGN,Mariani Peter J,"EVP, CFO",F - Tax,19.2,-918,21026,-4%,-17626.0,,,,,AXGN
63,,2021-07-21 16:13:44,2021-07-19,AXGN,Billet Isabelle,"Chief Strategy, BD Officer",A - Grant,0.0,2572,13360,+24%,0.0,,,,,AXGN
64,,2021-07-21 16:13:44,2021-07-20,AXGN,Billet Isabelle,"Chief Strategy, BD Officer",F - Tax,19.2,-728,13360,-5%,-13978.0,,,,,AXGN
65,,2021-07-21 16:13:18,2021-07-19,AXGN,Martinez Maria D.,CHRO,A - Grant,0.0,2572,4867,+112%,0.0,,,,,AXGN
66,,2021-07-21 16:13:18,2021-07-20,AXGN,Martinez Maria D.,CHRO,F - Tax,19.2,-637,4867,-12%,-12230.0,,,,,AXGN
67,,2021-07-21 16:12:57,2021-07-19,AXGN,Friedman Mark Louis,"VP Regulatory Affairs, Policy",A - Grant,0.0,2572,16308,+19%,0.0,,,,,AXGN
68,,2021-07-21 16:12:57,2021-07-20,AXGN,Friedman Mark Louis,"VP Regulatory Affairs, Policy",F - Tax,19.2,-637,16308,-4%,-12230.0,,,,,AXGN
69,D,2021-06-21 16:17:56,2021-06-17,AXGN,Freitag Gregory Gene,Dir,F - Tax,20.92,-8781,355775,-2%,-183699.0,,,,,AXGN
70,D,2021-06-21 16:17:56,2021-06-17,AXGN,Freitag Gregory Gene,Dir,M - OptEx,19.17,9250,355775,+3%,177323.0,,,,,AXGN
71,,2021-06-08 16:25:44,2021-06-04,AXGN,Martinez Maria D.,CHRO,S - Sale,18.86,-2652,2932,-47%,-50017.0,,,,,AXGN
72,D,2021-06-08 16:25:19,2021-06-04,AXGN,Freitag Gregory Gene,Dir,M - OptEx,3.67,24000,355306,+7%,88080.0,,,,,AXGN
73,AD,2021-06-07 17:25:12,2021-05-19,AXGN,Neels Guido J,Dir,M - OptEx,4.28,40000,42591,>999%,171350.0,,,,,AXGN
74,D,2021-06-03 17:15:50,2021-06-01,AXGN,Gold Mark Stephen,Dir,M - OptEx,0.0,6173,302439,+2%,0.0,,,,,AXGN
75,D,2021-06-03 17:14:20,2021-06-01,AXGN,Wendell Amy McBride,Dir,M - OptEx,0.0,6173,32097,+24%,0.0,,,,,AXGN
76,D,2021-06-03 17:13:20,2021-06-01,AXGN,Blackford Quentin S.,Dir,M - OptEx,0.0,6173,24299,+34%,0.0,,,,,AXGN
77,D,2021-06-03 17:12:49,2021-06-01,AXGN,Neels Guido J,Dir,M - OptEx,0.0,6173,48764,+14%,0.0,,,,,AXGN
78,D,2021-06-03 17:11:58,2021-06-01,AXGN,Levine Alan M,Dir,M - OptEx,0.0,6173,8764,+238%,0.0,,,,,AXGN
79,D,2021-05-28 16:05:58,2021-05-26,AXGN,Freitag Gregory Gene,Dir,M - OptEx,6.72,102954,331306,+45%,692001.0,,,,,AXGN
80,D,2021-05-21 16:21:33,2021-05-19,AXGN,Neels Guido J,Dir,M - OptEx,4.28,40000,42591,>999%,171350.0,,,,,AXGN
81,D,2021-04-30 16:10:49,2021-04-28,AXGN,Devinney Erick Wayne,"VP of Clin., Trans. Sciences",M - OptEx,2.86,10000,78082,+15%,28600.0,,,,,AXGN
82,D,2021-04-20 16:09:37,2021-04-16,AXGN,Zaderej Karen L.,CEO,M - OptEx,5.09,100000,765912,+15%,509000.0,,,,,AXGN
83,D,2021-03-29 16:17:39,2021-03-25,AXGN,Zaderej Karen L.,CEO,M - OptEx,3.67,34500,665912,+5%,126615.0,,,,,AXGN
84,,2021-03-01 16:08:52,2021-02-25,AXGN,Freitag Gregory Gene,Dir,S - Sale,22.06,-24000,228352,-10%,-529440.0,,,,,AXGN
85,,2021-02-19 16:12:37,2021-02-18,AXGN,Donovan Michael Patrick,VP Operations,S - Sale,19.15,-1808,40839,-4%,-34623.0,,,,,AXGN
86,,2021-02-18 17:27:24,2021-02-16,AXGN,Scopelianos Angelo,"Chief R, D Officer",A - Grant,0.0,1325,7046,+23%,0.0,,,,,AXGN
87,,2021-02-18 17:27:24,2021-02-17,AXGN,Scopelianos Angelo,"Chief R, D Officer",F - Tax,18.71,-406,7046,-5%,-7596.0,,,,,AXGN
88,,2021-02-18 17:26:51,2021-02-16,AXGN,Friedman Mark Louis,"VP, Regulatory, Quality",A - Grant,0.0,3111,13936,+29%,0.0,,,,,AXGN
89,,2021-02-18 17:26:51,2021-02-17,AXGN,Friedman Mark Louis,"VP, Regulatory, Quality",F - Tax,18.7,-951,13936,-6%,-17787.0,,,,,AXGN
90,,2021-02-18 17:26:20,2021-02-16,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",A - Grant,0.0,6231,68082,+10%,0.0,,,,,AXGN
91,,2021-02-18 17:26:20,2021-02-17,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",F - Tax,18.7,-1864,68082,-3%,-34857.0,,,,,AXGN
92,,2021-02-18 17:25:50,2021-02-16,AXGN,Sandberg Eric,Chief Commercial Officer,A - Grant,0.0,2531,3223,+366%,0.0,,,,,AXGN
93,,2021-02-18 17:25:50,2021-02-17,AXGN,Sandberg Eric,Chief Commercial Officer,F - Tax,18.7,-903,3223,-22%,-16886.0,,,,,AXGN
94,,2021-02-18 17:17:15,2021-02-16,AXGN,Donovan Michael Patrick,VP Operations,A - Grant,0.0,2605,42647,+7%,0.0,,,,,AXGN
95,,2021-02-18 17:17:15,2021-02-17,AXGN,Donovan Michael Patrick,VP Operations,F - Tax,18.71,-797,42647,-2%,-14912.0,,,,,AXGN
96,,2021-02-18 17:16:39,2021-02-16,AXGN,Freitag Gregory Gene,Dir,A - Grant,0.0,5161,252352,+2%,0.0,,,,,AXGN
97,,2021-02-18 17:16:39,2021-02-17,AXGN,Freitag Gregory Gene,Dir,F - Tax,18.7,-1577,252352,-1%,-29490.0,,,,,AXGN
98,,2021-02-18 17:15:56,2021-02-16,AXGN,Martinez Maria D.,CHRO,A - Grant,0.0,1325,5584,+31%,0.0,,,,,AXGN
99,,2021-02-18 17:15:56,2021-02-17,AXGN,Martinez Maria D.,CHRO,F - Tax,18.71,-406,5584,-7%,-7596.0,,,,,AXGN
100,,2021-02-18 17:15:34,2021-02-16,AXGN,Mariani Peter J,CFO,A - Grant,0.0,10812,18234,+146%,0.0,,,,,AXGN
101,,2021-02-18 17:15:34,2021-02-17,AXGN,Mariani Peter J,CFO,F - Tax,18.71,-2954,18234,-14%,-55261.0,,,,,AXGN
102,,2021-02-18 17:15:12,2021-02-16,AXGN,Zaderej Karen L.,CEO,A - Grant,0.0,29999,631412,+5%,0.0,,,,,AXGN
103,,2021-02-18 17:15:12,2021-02-17,AXGN,Zaderej Karen L.,CEO,F - Tax,18.71,-7686,631412,-1%,-143805.0,,,,,AXGN
104,,2021-02-18 17:14:38,2021-02-16,AXGN,Billet Isabelle,"Chief Strategy, BD Officer",A - Grant,0.0,1325,11080,+14%,0.0,,,,,AXGN
105,,2021-02-18 17:14:38,2021-02-17,AXGN,Billet Isabelle,"Chief Strategy, BD Officer",F - Tax,18.71,-454,11080,-4%,-8494.0,,,,,AXGN
106,D,2021-02-09 19:12:03,2021-02-05,AXGN,Donovan Michael Patrick,VP Operations,F - Tax,19.81,-5190,40839,-11%,-102814.0,,,,,AXGN
107,D,2021-02-09 19:12:03,2021-02-05,AXGN,Donovan Michael Patrick,VP Operations,M - OptEx,5.14,20000,40839,+96%,102800.0,,,,,AXGN
108,,2021-01-12 16:08:04,2021-01-08,AXGN,Zaderej Karen L.,CEO,S - Sale,20.0,-65000,609099,-10%,-1300000.0,,,,,AXGN
109,,2020-12-31 16:06:07,2020-12-30,AXGN,Donovan Michael Patrick,VP Operations,S - Sale,17.48,-1733,26029,-6%,-30293.0,,,,,AXGN
110,,2020-12-30 17:33:19,2020-12-27,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",A - Grant,0.0,1500,63240,+2%,0.0,,,,,AXGN
111,,2020-12-30 17:33:19,2020-12-29,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",S - Sale,17.81,-371,63240,-1%,-6608.0,,,,,AXGN
112,,2020-12-30 16:09:26,2020-12-27,AXGN,Donovan Michael Patrick,VP Operations,A - Grant,0.0,2300,27762,+9%,0.0,,,,,AXGN
113,,2020-12-30 16:09:26,2020-12-29,AXGN,Donovan Michael Patrick,VP Operations,S - Sale,17.81,-567,27762,-2%,-10098.0,,,,,AXGN
114,,2020-12-30 12:53:07,2020-12-27,AXGN,Freitag Gregory Gene,Dir,A - Grant,0.0,2300,248345,+1%,0.0,,,,,AXGN
115,,2020-12-30 12:53:07,2020-12-29,AXGN,Freitag Gregory Gene,Dir,S - Sale,17.81,-916,248345,0%,-16314.0,,,,,AXGN
116,,2020-12-30 11:56:12,2020-12-27,AXGN,Mariani Peter J,CFO,A - Grant,0.0,5250,10376,+102%,0.0,,,,,AXGN
117,,2020-12-30 11:56:12,2020-12-29,AXGN,Mariani Peter J,CFO,S - Sale,17.81,-1293,10376,-11%,-23028.0,,,,,AXGN
118,,2020-12-30 11:55:42,2020-12-27,AXGN,Scopelianos Angelo,"VP Research, Development",A - Grant,0.0,2300,5529,+71%,0.0,,,,,AXGN
119,,2020-12-30 11:55:42,2020-12-29,AXGN,Scopelianos Angelo,"VP Research, Development",S - Sale,17.81,-567,5529,-9%,-10098.0,,,,,AXGN
120,,2020-12-30 11:53:53,2020-12-27,AXGN,Zaderej Karen L.,CEO,A - Grant,0.0,8800,674099,+1%,0.0,,,,,AXGN
121,,2020-12-30 11:53:53,2020-12-29,AXGN,Zaderej Karen L.,CEO,S - Sale,17.81,-3500,674099,-1%,-62335.0,,,,,AXGN
122,,2020-12-30 11:52:19,2020-12-27,AXGN,Friedman Mark Louis,"VP,Regulatory, Quality",A - Grant,0.0,2300,11124,+26%,0.0,,,,,AXGN
123,,2020-12-30 11:52:19,2020-12-29,AXGN,Friedman Mark Louis,"VP,Regulatory, Quality",S - Sale,17.81,-567,11124,-5%,-10098.0,,,,,AXGN
124,,2020-12-30 11:51:45,2020-12-27,AXGN,Martinez Maria D.,CHRO,A - Grant,0.0,2300,4665,+97%,0.0,,,,,AXGN
125,,2020-12-30 11:51:45,2020-12-29,AXGN,Martinez Maria D.,CHRO,S - Sale,17.81,-567,4665,-11%,-10098.0,,,,,AXGN
126,,2020-12-30 11:51:12,2020-12-27,AXGN,Billet Isabelle,"Chief Strategy, BD Officer",A - Grant,0.0,2300,9496,+32%,0.0,,,,,AXGN
127,,2020-12-30 11:51:12,2020-12-29,AXGN,Billet Isabelle,"Chief Strategy, BD Officer",S - Sale,17.81,-649,9496,-6%,-11559.0,,,,,AXGN
128,D,2020-12-28 09:26:07,2020-12-23,AXGN,Zaderej Karen L.,CEO,M - OptEx,4.81,19375,666094,+3%,93194.0,,,,,AXGN
129,,2020-12-23 14:32:23,2020-12-22,AXGN,Donovan Michael Patrick,VP Operations,S - Sale,17.19,-279,26029,-1%,-4796.0,,,,,AXGN
130,,2020-12-22 17:32:35,2020-12-18,AXGN,Zaderej Karen L.,CEO,A - Grant,0.0,3125,646719,0%,0.0,,,,,AXGN
131,,2020-12-22 17:32:35,2020-12-21,AXGN,Zaderej Karen L.,CEO,S - Sale,16.42,-1275,646719,0%,-20936.0,,,,,AXGN
132,,2020-12-22 15:22:53,2020-12-18,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",A - Grant,0.0,575,62111,+1%,0.0,,,,,AXGN
133,,2020-12-22 15:22:53,2020-12-21,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",S - Sale,16.42,-147,62111,0%,-2414.0,,,,,AXGN
134,,2020-12-22 15:15:41,2020-12-18,AXGN,Freitag Gregory Gene,Dir,A - Grant,0.0,925,245076,0%,0.0,,,,,AXGN
135,,2020-12-22 15:15:41,2020-12-21,AXGN,Freitag Gregory Gene,Dir,S - Sale,16.42,-379,245076,0%,-6223.0,,,,,AXGN
136,,2020-12-22 13:55:36,2020-12-18,AXGN,Donovan Michael Patrick,VP Operations,A - Grant,0.0,375,26308,+1%,0.0,,,,,AXGN
137,,2020-12-22 13:55:36,2020-12-21,AXGN,Donovan Michael Patrick,VP Operations,S - Sale,16.42,-96,26308,0%,-1576.0,,,,,AXGN
138,,2020-12-22 12:54:40,2020-12-18,AXGN,Mariani Peter J,CFO,A - Grant,0.0,1900,6419,+42%,0.0,,,,,AXGN
139,,2020-12-22 12:54:40,2020-12-21,AXGN,Mariani Peter J,CFO,S - Sale,16.42,-481,6419,-7%,-7898.0,,,,,AXGN
140,,2020-12-22 11:38:38,2020-12-18,AXGN,Friedman Mark Louis,"VP,Regulatory, Quality",A - Grant,0.0,375,8893,+4%,0.0,,,,,AXGN
141,,2020-12-22 11:38:38,2020-12-21,AXGN,Friedman Mark Louis,"VP,Regulatory, Quality",S - Sale,16.42,-96,8893,-1%,-1576.0,,,,,AXGN
142,D,2020-12-17 16:41:17,2020-12-15,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",F - Tax,16.5,-4373,61683,-7%,-72155.0,,,,,AXGN
143,D,2020-12-17 16:41:17,2020-12-15,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",M - OptEx,4.81,15000,61683,+32%,72150.0,,,,,AXGN
144,D,2020-12-07 14:39:09,2020-12-03,AXGN,Friedman Mark Louis,"VP,Regulatory, Quality",M - OptEx,3.86,3812,8614,+79%,14703.0,,,,,AXGN
145,,2020-11-12 10:14:27,2020-11-09,AXGN,Donovan Michael Patrick,VP Operations,S - Sale,15.0,-17617,26029,-40%,-264255.0,,,,,AXGN
146,,2020-11-10 09:56:56,2020-11-09,AXGN,Zaderej Karen L.,CEO,S - Sale,14.53,-14000,644869,-2%,-203420.0,,,,,AXGN
147,,2020-11-05 18:19:09,2020-11-04,AXGN,Gold Mark Stephen,Dir,G - Gift,0.0,-15596,296266,-5%,-0.0,,,,,AXGN
148,D,2020-11-03 17:11:11,2020-10-30,AXGN,Mariani Peter J,CFO,M - OptEx,5.04,60000,5000,-109%,302400.0,,,,,AXGN
149,D,2020-11-03 17:11:11,2020-10-30,AXGN,Mariani Peter J,CFO,S - Sale+OE,12.41,-75683,5000,-94%,-939353.0,,,,,AXGN
150,D,2020-09-17 16:57:03,2020-09-15,AXGN,Freitag Gregory Gene,Dir,M - OptEx,3.67,13046,244530,+6%,47879.0,,,,,AXGN
151,,2020-09-08 17:37:22,2020-09-03,AXGN,Neels Guido J,Dir,A - Grant,11.75,2591,2591,New,30444.0,,,,,AXGN
152,,2020-09-08 17:37:06,2020-09-03,AXGN,Rudelius Robert James,Dir,A - Grant,11.75,2591,48183,+6%,30444.0,,,,,AXGN
153,,2020-09-08 17:36:52,2020-09-03,AXGN,Wendell Amy McBride,Dir,A - Grant,11.75,2591,25924,+11%,30444.0,,,,,AXGN
154,,2020-09-08 17:36:37,2020-09-03,AXGN,Levine Alan M,Dir,A - Grant,11.75,2591,2591,New,30444.0,,,,,AXGN
155,,2020-09-08 17:36:23,2020-09-03,AXGN,Blackford Quentin S.,Dir,A - Grant,11.75,2591,18126,+17%,30444.0,,,,,AXGN
156,,2020-09-08 11:05:16,2020-09-03,AXGN,Gold Mark Stephen,Dir,A - Grant,11.75,2591,311862,+1%,30444.0,,,,,AXGN
157,,2020-08-13 15:25:53,2020-08-12,AXGN,Gold Mark Stephen,Dir,G - Gift,0.0,-17500,309271,-5%,-0.0,,,,,AXGN
158,AM,2020-06-05 16:48:30,2019-08-09,AXGN,Blackford Quentin S.,Dir,P - Purchase,14.01,15535,15535,New,217673.0,,,,,AXGN
159,D,2020-06-01 07:08:23,2020-05-28,AXGN,Donovan Michael Patrick,VP Operations,M - OptEx,4.16,15000,43646,+52%,62400.0,,,,,AXGN
160,D,2020-06-01 07:08:02,2020-05-29,AXGN,Freitag Gregory Gene,GC,M - OptEx,3.5,125000,231484,+117%,437500.0,,,,,AXGN
161,D,2020-04-29 17:56:23,2020-04-28,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",M - OptEx,0.27,2530,51056,+5%,683.0,,,,,AXGN
162,D,2020-04-20 08:17:00,2020-04-16,AXGN,Zaderej Karen L.,CEO,M - OptEx,4.81,11625,658869,+2%,55916.0,,,,,AXGN
163,,2020-02-20 16:17:49,2020-02-18,AXGN,Zaderej Karen L.,CEO,A - Grant,0.0,29993,647244,+5%,0.0,,,,,AXGN
164,,2020-02-20 16:17:49,2020-02-18,AXGN,Zaderej Karen L.,CEO,F - Tax,14.68,-5429,647244,-1%,-79698.0,,,,,AXGN
165,,2020-02-20 16:17:27,2020-02-18,AXGN,Donovan Michael Patrick,VP Operations,A - Grant,0.0,2605,28646,+10%,0.0,,,,,AXGN
166,,2020-02-20 16:17:10,2020-02-18,AXGN,Scopelianos Angelo,"VP Research, Development",A - Grant,0.0,1326,2249,+144%,0.0,,,,,AXGN
167,,2020-02-20 16:17:10,2020-02-18,AXGN,Scopelianos Angelo,"VP Research, Development",F - Tax,14.68,-394,2249,-15%,-5784.0,,,,,AXGN
168,,2020-02-20 16:16:55,2020-02-18,AXGN,Mariani Peter J,CFO,A - Grant,0.0,10811,20683,+110%,0.0,,,,,AXGN
169,,2020-02-20 16:16:55,2020-02-18,AXGN,Mariani Peter J,CFO,F - Tax,14.68,-3256,20683,-14%,-47798.0,,,,,AXGN
170,,2020-02-20 13:25:31,2020-02-18,AXGN,Friedman Mark Louis,"VP,Regulatory, Quality",A - Grant,0.0,3111,4802,+184%,0.0,,,,,AXGN
171,,2020-02-20 13:25:31,2020-02-18,AXGN,Friedman Mark Louis,"VP,Regulatory, Quality",F - Tax,14.68,-924,4802,-16%,-13564.0,,,,,AXGN
172,,2020-02-20 13:19:54,2020-02-18,AXGN,Sandberg Eric,Chief Commercial Officer,A - Grant,0.0,2531,1595,-270%,0.0,,,,,AXGN
173,,2020-02-20 13:19:54,2020-02-18,AXGN,Sandberg Eric,Chief Commercial Officer,F - Tax,14.68,-936,1595,-37%,-13740.0,,,,,AXGN
174,,2020-02-20 13:19:38,2020-02-18,AXGN,Freitag Gregory Gene,GC,A - Grant,0.0,5160,106484,+5%,0.0,,,,,AXGN
175,,2020-02-20 13:19:38,2020-02-18,AXGN,Freitag Gregory Gene,GC,F - Tax,14.68,-1531,106484,-1%,-22475.0,,,,,AXGN
176,,2020-02-20 13:19:16,2020-02-18,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",A - Grant,0.0,6230,48526,+15%,0.0,,,,,AXGN
177,,2020-02-20 13:19:16,2020-02-18,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",F - Tax,14.68,-1849,48526,-4%,-27143.0,,,,,AXGN
178,,2020-02-20 13:18:55,2020-02-18,AXGN,Billet Isabelle,"Chief Strategy, BD Officer",A - Grant,0.0,1326,6521,+26%,0.0,,,,,AXGN
179,,2020-02-20 13:18:55,2020-02-18,AXGN,Billet Isabelle,"Chief Strategy, BD Officer",F - Tax,14.68,-440,6521,-6%,-6459.0,,,,,AXGN
180,,2020-02-20 13:18:37,2020-02-18,AXGN,Martinez Maria D.,CHRO,A - Grant,0.0,1326,2932,+83%,0.0,,,,,AXGN
181,,2020-02-20 13:18:37,2020-02-18,AXGN,Martinez Maria D.,CHRO,F - Tax,14.68,-394,2932,-12%,-5784.0,,,,,AXGN
182,,2020-01-17 20:41:21,2020-01-01,AXGN,Zaderej Karen L.,CEO,A - Grant,0.0,40000,622680,+7%,0.0,,,,,AXGN
183,,2020-01-17 20:41:21,2020-01-01,AXGN,Zaderej Karen L.,CEO,D - Sale to issuer,17.34,-10112,622680,-2%,-175342.0,,,,,AXGN
184,D,2020-01-03 08:03:03,2020-01-01,AXGN,Rudelius Robert James,Dir,F - Tax,17.89,-1999,45592,-4%,-35762.0,,,,,AXGN
185,D,2020-01-03 08:03:03,2020-01-01,AXGN,Rudelius Robert James,Dir,M - OptEx,2.75,13000,45592,+40%,35750.0,,,,,AXGN
186,,2019-12-20 16:28:04,2019-12-18,AXGN,Zaderej Karen L.,CEO,A - Grant,0.0,6250,599530,+1%,0.0,,,,,AXGN
187,,2019-12-20 16:27:50,2019-12-18,AXGN,Friedman Mark Louis,"VP,Regulatory, Quality",A - Grant,0.0,750,2127,+54%,0.0,,,,,AXGN
188,,2019-12-20 16:27:50,2019-12-18,AXGN,Friedman Mark Louis,"VP,Regulatory, Quality",F - Tax,16.73,-183,2127,-8%,-3062.0,,,,,AXGN
189,,2019-12-20 16:27:34,2019-12-18,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",A - Grant,0.0,1150,42840,+3%,0.0,,,,,AXGN
190,,2019-12-20 16:27:34,2019-12-18,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",F - Tax,16.73,-281,42840,-1%,-4701.0,,,,,AXGN
191,,2019-12-20 16:27:19,2019-12-18,AXGN,Mariani Peter J,CFO,A - Grant,0.0,3800,12433,+44%,0.0,,,,,AXGN
192,,2019-12-20 16:27:19,2019-12-18,AXGN,Mariani Peter J,CFO,F - Tax,16.73,-1049,12433,-8%,-17550.0,,,,,AXGN
193,,2019-12-20 16:16:54,2019-12-18,AXGN,Donovan Michael Patrick,VP Operations,A - Grant,0.0,750,26041,+3%,0.0,,,,,AXGN
194,,2019-12-20 16:16:54,2019-12-18,AXGN,Donovan Michael Patrick,VP Operations,F - Tax,16.73,-183,26041,-1%,-3062.0,,,,,AXGN
195,,2019-12-20 16:16:37,2019-12-18,AXGN,Freitag Gregory Gene,GC,A - Grant,0.0,1850,101543,+2%,0.0,,,,,AXGN
196,,2019-12-20 16:16:37,2019-12-18,AXGN,Freitag Gregory Gene,GC,F - Tax,16.73,-567,101543,-1%,-9486.0,,,,,AXGN
197,,2019-12-05 20:40:58,2019-12-03,AXGN,Gold Mark Stephen,Dir,G - Gift,0.0,-7000,326771,-2%,-0.0,,,,,AXGN
198,,2019-11-26 18:03:19,2019-11-22,AXGN,Gold Mark Stephen,Dir,G - Gift,0.0,-13090,333771,-4%,-0.0,,,,,AXGN
199,D,2019-10-10 21:32:42,2019-10-08,AXGN,Donovan Michael Patrick,VP Operations,M - OptEx,4.37,6500,25474,+34%,28400.0,,,,,AXGN
200,,2019-08-15 16:03:41,2019-08-09,AXGN,Gold Mark Stephen,Dir,P - Purchase,13.1,4000,348761,+1%,52389.0,,,,,AXGN
201,,2019-08-14 16:23:35,2019-08-13,AXGN,Billet Isabelle,"Chief Strategy, BD Officer",P - Purchase,15.11,5635,5635,New,85139.0,,,,,AXGN
202,,2019-08-14 16:23:12,2019-08-14,AXGN,Martinez Maria D.,CHRO,P - Purchase,15.13,2000,2000,New,30260.0,,,,,AXGN
203,M,2019-08-13 08:45:10,2019-08-09,AXGN,Blackford Quentin S.,Dir,P - Purchase,14.01,15535,39468,+65%,217673.0,,,,,AXGN
204,,2019-08-12 08:59:54,2019-08-09,AXGN,Zaderej Karen L.,CEO,P - Purchase,13.5,75000,593280,+14%,1012425.0,,,,,AXGN
205,,2019-06-14 16:34:45,2019-06-13,AXGN,Donovan Michael Patrick,VP Operations,S - Sale,20.0,-20000,18974,-51%,-400000.0,,,,,AXGN
206,,2019-06-14 16:31:49,2019-06-13,AXGN,Wendell Amy McBride,Dir,P - Purchase,20.25,5000,23333,+27%,101250.0,,,,,AXGN
207,D,2019-05-31 16:07:25,2019-05-29,AXGN,Zaderej Karen L.,CEO,M - OptEx,0.27,18056,510280,+4%,4875.0,,,,,AXGN
208,,2019-05-17 21:47:54,2019-05-17,AXGN,Friedman Mark Louis,"VP,Regulatory, Quality",D - Sale to issuer,21.14,-67952,1560,-98%,-1436594.0,,,,,AXGN
209,,2019-05-16 21:14:44,2019-05-13,AXGN,Hansen David K,"VP Finance, Treasurer",S - Sale,22.63,-20000,25588,-44%,-452600.0,,,,,AXGN
210,,2019-02-19 13:25:55,2019-02-15,AXGN,Zaderej Karen L.,CEO,A - Grant,17.57,16015,492224,+3%,281384.0,,,,,AXGN
211,,2019-02-19 13:25:41,2019-02-15,AXGN,Freitag Gregory Gene,GC,A - Grant,17.57,3377,100260,+3%,59334.0,,,,,AXGN
212,,2019-02-19 13:25:27,2019-02-15,AXGN,Mariani Peter J,CFO,A - Grant,0.0,7654,9682,+377%,0.0,,,,,AXGN
213,,2019-02-19 13:25:27,2019-02-15,AXGN,Mariani Peter J,CFO,F - Tax,17.57,-2355,9682,-20%,-41377.0,,,,,AXGN
214,,2019-02-19 13:25:08,2019-02-15,AXGN,Friedman Mark Louis,"VP,Regulatory, Quality",A - Grant,0.0,1930,69512,+3%,0.0,,,,,AXGN
215,,2019-02-19 13:25:08,2019-02-15,AXGN,Friedman Mark Louis,"VP,Regulatory, Quality",F - Tax,17.57,-573,69512,-1%,-10068.0,,,,,AXGN
216,,2019-02-19 13:24:45,2019-02-15,AXGN,Hansen David K,"VP Finance, Treasurer",A - Grant,0.0,1930,45588,+4%,0.0,,,,,AXGN
217,,2019-02-19 13:24:45,2019-02-15,AXGN,Hansen David K,"VP Finance, Treasurer",F - Tax,17.57,-573,45588,-1%,-10068.0,,,,,AXGN
218,,2019-02-19 13:24:32,2019-02-15,AXGN,Donovan Michael Patrick,VP Operations,A - Grant,0.0,1930,38974,+5%,0.0,,,,,AXGN
219,,2019-02-19 13:24:32,2019-02-15,AXGN,Donovan Michael Patrick,VP Operations,F - Tax,17.57,-573,38974,-1%,-10068.0,,,,,AXGN
220,,2019-02-19 13:24:16,2019-02-15,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",A - Grant,0.0,5079,41971,+14%,0.0,,,,,AXGN
221,,2019-02-19 13:24:16,2019-02-15,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",F - Tax,17.57,-1498,41971,-3%,-26320.0,,,,,AXGN
222,,2019-02-19 13:24:00,2019-02-15,AXGN,Gingrich Jon S.,Chief Commercial Officer,A - Grant,0.0,3859,4190,>999%,0.0,,,,,AXGN
223,,2019-02-19 13:24:00,2019-02-15,AXGN,Gingrich Jon S.,Chief Commercial Officer,F - Tax,17.57,-1342,4190,-24%,-23579.0,,,,,AXGN
224,D,2018-12-21 09:29:22,2018-11-19,AXGN,Zaderej Karen L.,CEO,M - OptEx,2.74,30000,476209,+7%,82200.0,,,,,AXGN
225,,2018-12-04 19:30:47,2018-11-30,AXGN,Freitag Gregory Gene,GC,S - Sale,33.0,-45000,95865,-32%,-1485000.0,,,,,AXGN
226,D,2018-11-21 16:26:48,2018-11-19,AXGN,Zaderej Karen L.,CEO,F - Tax,28.37,-6761,446209,-1%,-191810.0,,,,,AXGN
227,D,2018-11-21 16:26:48,2018-11-19,AXGN,Zaderej Karen L.,CEO,M - OptEx,2.74,70000,446209,+19%,191800.0,,,,,AXGN
228,D,2018-11-15 17:18:51,2018-11-13,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",F - Tax,33.28,-2882,37410,-7%,-95913.0,,,,,AXGN
229,D,2018-11-15 17:18:51,2018-11-13,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",M - OptEx,2.72,35274,37410,>999%,95974.0,,,,,AXGN
230,,2018-11-15 17:16:46,2018-11-15,AXGN,Freitag Gregory Gene,GC,S - Sale,32.25,-20000,140865,-12%,-645000.0,,,,,AXGN
231,M,2018-11-15 17:14:06,2018-11-13,AXGN,Zaderej Karen L.,CEO,S - Sale,33.18,-25000,382970,-6%,-829620.0,,,,,AXGN
232,,2018-10-03 20:39:43,2018-10-02,AXGN,Gold Mark Stephen,Dir,G - Gift,0.0,-20000,344761,-5%,-0.0,,,,,AXGN
233,D,2018-09-24 16:43:44,2018-09-20,AXGN,Grooms Jamie Mark,Dir,M - OptEx,2.65,12494,18693,+202%,33133.0,,,,,AXGN
234,,2018-08-16 17:10:21,2018-08-14,AXGN,Wendell Amy McBride,Dir,P - Purchase,36.89,5000,18333,+38%,184450.0,,,,,AXGN
235,,2018-08-13 17:01:33,2018-08-09,AXGN,Gold Mark Stephen,Dir,G - Gift,0.0,-30487,344761,-8%,-0.0,,,,,AXGN
236,D,2018-08-09 16:44:55,2018-08-07,AXGN,McCarrey Shawn F,SVP Sales,F - Tax,39.3,-5136,82921,-6%,-201845.0,,,,,AXGN
237,D,2018-08-09 16:44:55,2018-08-07,AXGN,McCarrey Shawn F,SVP Sales,M - OptEx,3.67,55000,82921,+197%,201850.0,,,,,AXGN
238,,2018-08-09 16:44:33,2018-08-07,AXGN,Zaderej Karen L.,CEO,F - Tax,39.3,-10060,407970,-2%,-395358.0,,,,,AXGN
239,D,2018-08-06 18:00:52,2018-08-02,AXGN,Zaderej Karen L.,CEO,M - OptEx,2.74,175000,418030,+72%,479500.0,,,,,AXGN
240,D,2018-06-12 16:42:30,2018-06-08,AXGN,Rudelius Robert James,Dir,F - Tax,48.4,-682,34591,-2%,-33009.0,,,,,AXGN
241,D,2018-06-12 16:42:30,2018-06-08,AXGN,Rudelius Robert James,Dir,M - OptEx,2.75,12000,34591,+53%,33000.0,,,,,AXGN
242,D,2018-06-05 17:02:02,2018-06-01,AXGN,Gold Mark Stephen,Dir,M - OptEx,14.85,15000,375248,+4%,222750.0,,,,,AXGN
243,,2018-05-18 18:25:13,2018-05-16,AXGN,McCarrey Shawn F,SVP Sales,S - Sale,43.47,-10000,33057,-23%,-434700.0,,,,,AXGN
244,D,2018-03-27 18:45:43,2018-03-26,AXGN,Donovan Michael Patrick,VP Operations,F - Tax,40.25,-2042,37617,-5%,-82191.0,,,,,AXGN
245,D,2018-03-27 18:45:43,2018-03-26,AXGN,Donovan Michael Patrick,VP Operations,M - OptEx,2.74,30000,37617,+394%,82200.0,,,,,AXGN
246,D,2018-03-26 18:13:07,2018-03-22,AXGN,Hansen David K,"VP Finance, Treasurer",F - Tax,39.55,-2529,43792,-5%,-100022.0,,,,,AXGN
247,D,2018-03-26 18:13:07,2018-03-22,AXGN,Hansen David K,"VP Finance, Treasurer",M - OptEx,2.74,36500,43792,+501%,100025.0,,,,,AXGN
248,D,2018-03-23 08:44:59,2018-03-21,AXGN,Freitag Gregory Gene,"GC, SVP BD",F - Tax,38.5,-2896,160865,-2%,-111496.0,,,,,AXGN
249,D,2018-03-23 08:44:59,2018-03-21,AXGN,Freitag Gregory Gene,"GC, SVP BD",M - OptEx,3.6,31000,160865,+24%,111510.0,,,,,AXGN
250,D,2018-03-05 17:27:39,2018-03-01,AXGN,Freitag Gregory Gene,"GC, SVP BD",F - Tax,33.95,-2905,132761,-2%,-98625.0,,,,,AXGN
251,D,2018-03-05 17:27:39,2018-03-01,AXGN,Freitag Gregory Gene,"GC, SVP BD",M - OptEx,2.74,36000,132761,+37%,98640.0,,,,,AXGN
252,,2018-02-23 19:08:12,2018-02-21,AXGN,Grooms Jamie Mark,Dir,S - Sale,28.4,-57406,6199,-90%,-1630330.0,,,,,AXGN
253,M,2018-02-20 19:52:55,2018-02-16,AXGN,Grooms Jamie Mark,Dir,S - Sale,27.67,-63395,62861,-50%,-1754060.0,,,,,AXGN
254,,2018-02-20 07:55:34,2018-02-16,AXGN,McCarrey Shawn F,SVP Sales,A - Grant,0.0,7150,43057,+20%,0.0,,,,,AXGN
255,,2018-02-20 07:55:34,2018-02-16,AXGN,McCarrey Shawn F,SVP Sales,F - Tax,27.4,-3260,43057,-7%,-89324.0,,,,,AXGN
256,AM,2018-02-16 20:14:27,2018-02-13,AXGN,Grooms Jamie Mark,Dir,S - Sale,26.84,-95712,126256,-43%,-2568969.0,,,,,AXGN
257,M,2018-02-15 19:56:42,2018-02-13,AXGN,Grooms Jamie Mark,"VP, CFO",S - Sale,26.84,-95712,126256,-43%,-2568969.0,,,,,AXGN
258,M,2017-12-13 19:45:09,2017-12-11,AXGN,Grooms Jamie Mark,Dir,S - Sale,26.35,-38405,240607,-14%,-1011806.0,,,,,AXGN
259,AM,2017-12-13 19:44:27,2017-12-06,AXGN,Grooms Jamie Mark,Dir,S - Sale,26.37,-86595,279012,-24%,-2283667.0,,,,,AXGN
260,M,2017-12-08 18:30:24,2017-12-06,AXGN,Grooms Jamie Mark,Dir,S - Sale,26.38,-84295,281312,-23%,-2223722.0,,,,,AXGN
261,,2017-11-21 15:31:08,2017-11-20,AXGN,"Essex Woodlands Fund Ix, L.P.",10%,S - Sale,19.74,-1150000,3711111,-24%,-22701000.0,,,,,AXGN
262,,2017-11-21 15:31:00,2017-11-20,AXGN,Neels Guido J,Dir,S - Sale,19.74,-1150000,3371111,-25%,-22701000.0,,,,,AXGN
263,D,2017-11-15 11:22:35,2017-11-13,AXGN,Gold Mark Stephen,Dir,M - OptEx,5.09,15000,360248,+4%,76350.0,,,,,AXGN
264,D,2017-11-03 16:56:08,2017-11-01,AXGN,Grooms Jamie Mark,Dir,F - Tax,20.6,-189,365607,0%,-3893.0,,,,,AXGN
265,D,2017-11-03 16:56:08,2017-11-01,AXGN,Grooms Jamie Mark,Dir,M - OptEx,0.27,14379,365607,+4%,3882.0,,,,,AXGN
266,D,2017-09-27 17:22:34,2017-09-25,AXGN,Freitag Gregory Gene,"GC, SVP BD",F - Tax,18.9,-1450,99666,-1%,-27405.0,,,,,AXGN
267,D,2017-09-27 17:22:34,2017-09-25,AXGN,Freitag Gregory Gene,"GC, SVP BD",M - OptEx,2.74,10000,99666,+11%,27400.0,,,,,AXGN
268,D,2017-09-12 16:02:25,2017-09-08,AXGN,Rudelius Robert James,Dir,F - Tax,18.15,-3857,23273,-14%,-70005.0,,,,,AXGN
269,D,2017-09-12 16:02:25,2017-09-08,AXGN,Rudelius Robert James,Dir,M - OptEx,3.5,20000,23273,+611%,70000.0,,,,,AXGN
270,D,2017-09-12 16:02:25,2017-09-11,AXGN,Rudelius Robert James,Dir,S - Sale+OE,18.0,-16143,23273,-41%,-290574.0,,,,,AXGN
271,D,2017-08-29 16:58:19,2017-08-27,AXGN,Freitag Gregory Gene,"GC, SVP BD",F - Tax,16.65,-3785,91116,-4%,-63020.0,,,,,AXGN
272,D,2017-08-29 16:58:19,2017-08-27,AXGN,Freitag Gregory Gene,"GC, SVP BD",M - OptEx,2.74,23000,91116,+34%,63020.0,,,,,AXGN
273,,2017-08-04 17:10:44,2017-08-02,AXGN,McCarrey Shawn F,SVP Sales,A - Grant,0.0,7150,39167,+22%,0.0,,,,,AXGN
274,,2017-08-04 17:10:44,2017-08-02,AXGN,McCarrey Shawn F,SVP Sales,F - Tax,15.15,-2383,39167,-6%,-36102.0,,,,,AXGN
275,D,2017-06-01 13:51:25,2017-05-30,AXGN,Gold Mark Stephen,Dir,M - OptEx,8.95,5000,345248,+1%,44750.0,,,,,AXGN
276,D,2017-05-26 16:24:47,2017-05-22,AXGN,Gold Mark Stephen,Dir,M - OptEx,4.81,15000,340248,+5%,72150.0,,,,,AXGN
277,D,2017-03-14 19:32:27,2017-03-14,AXGN,Devinney Erick Wayne,"VP, Clinical, Translational Sc",M - OptEx,0.27,5018,5018,New,1355.0,2.0,4.0,12.0,,AXGN
278,D,2017-03-14 19:32:03,2017-03-14,AXGN,Donovan Michael Patrick,VP Operations,M - OptEx,1.55,9659,9659,New,14958.0,2.0,4.0,12.0,,AXGN
279,D,2017-03-14 19:31:38,2016-12-30,AXGN,Freitag Gregory Gene,"GC, SVP BD",M - OptEx,2.74,23000,71901,+47%,63020.0,2.0,4.0,12.0,,AXGN
280,D,2017-01-03 17:23:05,2016-12-29,AXGN,Zaderej Karen L.,CEO,A - Grant,0.0,40000,282147,+17%,0.0,1.0,16.0,21.0,,AXGN
281,,2016-10-14 15:36:29,2016-10-07,AXGN,Wendell Amy McBride,Dir,P - Purchase,7.5,13333,13333,New,99998.0,0.0,3.0,-2.0,34.0,AXGN
282,,2016-10-14 15:14:17,2016-10-07,AXGN,Leach Kevin,VP Marketing,P - Purchase,7.5,2000,2000,New,15000.0,0.0,3.0,-2.0,34.0,AXGN
283,,2016-10-14 15:13:56,2016-10-07,AXGN,Mariani Peter J,CFO,P - Purchase,7.5,3333,3333,New,24998.0,0.0,3.0,-2.0,34.0,AXGN
284,,2016-10-14 13:37:42,2016-10-07,AXGN,Zaderej Karen L.,CEO,P - Purchase,7.5,10000,242147,+4%,75000.0,0.0,3.0,-2.0,34.0,AXGN
285,,2016-10-14 13:37:21,2016-10-07,AXGN,Engels John P,VP,P - Purchase,7.5,4000,98425,+4%,30000.0,0.0,3.0,-2.0,34.0,AXGN
286,D,2016-08-19 15:25:11,2016-08-17,AXGN,Gold Mark Stephen,Dir,M - OptEx,3.6,3750,325248,+1%,13500.0,1.0,-1.0,-5.0,21.0,AXGN
287,M,2016-08-10 19:28:38,2016-08-08,AXGN,Mandato Joseph M,Dir,S - Sale,8.54,-149618,1226773,-11%,-1277288.0,8.0,6.0,13.0,27.0,AXGN
288,,2016-07-21 16:26:14,2016-07-21,AXGN,Flynn James E,"Possible Member of 10% Group, 10%",S - Sale,6.7,-102136,3000000,-3%,-684311.0,0.0,1.0,33.0,47.0,AXGN
289,M,2016-07-18 18:20:15,2016-07-14,AXGN,Flynn James E,"Possible Member of 10% Group, 10%",S - Sale,7.53,-279303,3102136,-8%,-2104171.0,0.0,-3.0,30.0,52.0,AXGN
290,D,2016-06-01 17:00:39,2016-05-31,AXGN,Hansen David K,Chief Accounting Officer,M - OptEx,0.27,9821,9821,New,2652.0,0.0,1.0,17.0,49.0,AXGN
291,D,2015-11-12 18:55:51,2015-11-12,AXGN,Gold Mark Stephen,Dir,M - OptEx,3.6,11250,321498,+4%,40500.0,-2.0,1.0,-6.0,0.0,AXGN
292,,2015-11-12 09:24:32,2015-11-06,AXGN,Gold Mark Stephen,Dir,S - Sale,5.7,-6013,310248,-2%,-34274.0,-4.0,-3.0,-10.0,-4.0,AXGN
293,,2015-09-22 13:05:59,2015-09-18,AXGN,Flynn James E,"Possible Member of 10% Group, 10%",S - Sale,5.5,-345000,3381439,-9%,-1897983.0,-3.0,-21.0,-15.0,-2.0,AXGN
294,,2015-09-10 15:41:57,2015-09-08,AXGN,Gold Mark Stephen,Dir,M - OptEx,2.75,13000,316261,+4%,35750.0,-2.0,13.0,-3.0,5.0,AXGN
295,,2015-06-05 15:14:27,2015-06-03,AXGN,Mandato Joseph M,Dir,P - Purchase,3.1,6500,1426392,0%,20150.0,3.0,2.0,3.0,74.0,AXGN
296,,2015-06-03 16:46:18,2015-06-02,AXGN,Johnston Lee Robert Jr,Chief Finacial Officer,P - Purchase,3.06,5000,25000,+25%,15303.0,-1.0,5.0,3.0,78.0,AXGN
297,,2015-05-29 14:58:23,2015-05-27,AXGN,Zaderej Karen L.,CEO,P - Purchase,3.16,3325,232147,+1%,10493.0,1.0,2.0,5.0,80.0,AXGN
298,,2015-04-09 13:55:35,2015-04-08,AXGN,Flynn James E,"Possible Member of 10% Group, 10%",S - Sale,3.25,-144385,3726439,-4%,-469251.0,6.0,8.0,2.0,41.0,AXGN
299,A,2015-03-12 09:21:08,2014-09-30,AXGN,Gold Mark Stephen,Dir,M - OptEx,1.07,290,303261,0%,310.0,1.0,3.0,6.0,53.0,AXGN
300,,2015-02-12 15:44:44,2015-02-10,AXGN,Zaderej Karen L.,CEO,A - Grant,2.75,9600,228822,+4%,26400.0,4.0,-4.0,-2.0,19.0,AXGN
301,,2015-02-12 15:44:11,2015-02-10,AXGN,Freitag Gregory Gene,GC,A - Grant,2.75,4800,48902,+11%,13200.0,4.0,-4.0,-2.0,19.0,AXGN
302,,2015-02-12 15:43:13,2015-02-10,AXGN,McCarrey Shawn F,SVP of Sales,A - Grant,2.75,4400,34400,+15%,12100.0,4.0,-4.0,-2.0,19.0,AXGN
303,DM,2015-01-06 18:25:49,2014-12-10,AXGN,Mandato Joseph M,Dir,S - Sale+OE,3.06,-50000,1419892,-3%,-153092.0,9.0,7.0,-7.0,-14.0,AXGN
304,,2014-12-11 15:39:16,2014-12-10,AXGN,Johnston Lee Robert Jr,CFO,P - Purchase,3.06,10000,10000,New,30600.0,10.0,10.0,32.0,6.0,AXGN
305,,2014-12-03 21:57:46,2014-12-01,AXGN,Mandato Joseph M,Dir,A - Grant,2.94,6000,1469892,0%,17640.0,5.0,6.0,17.0,-1.0,AXGN
306,D,2014-10-02 18:08:21,2014-09-30,AXGN,Gold Mark Stephen,Dir,M - OptEx,1.07,290,303261,0%,310.0,0.0,8.0,2.0,26.0,AXGN
307,,2014-08-15 07:44:00,2014-08-12,AXGN,Gold Mark Stephen,Dir,P - Purchase,2.29,20000,302971,+7%,45800.0,11.0,27.0,10.0,60.0,AXGN
308,,2014-08-12 17:00:45,2014-08-08,AXGN,Mandato Joseph M,Dir,A - Grant,2.3,7500,1463892,+1%,17275.0,-1.0,1.0,7.0,40.0,AXGN
309,,2014-08-11 13:15:09,2014-08-08,AXGN,Gold Mark Stephen,Dir,P - Purchase,2.31,11000,282971,+4%,25410.0,-1.0,6.0,9.0,47.0,AXGN
310,,2014-06-10 17:15:50,2014-06-06,AXGN,Johnston Lee Robert Jr,CFO,P - Purchase,2.58,10000,10000,New,25757.0,3.0,2.0,-9.0,26.0,AXGN
311,,2014-06-04 15:54:57,2014-06-03,AXGN,Zaderej Karen L.,CEO,P - Purchase,2.43,5000,334056,+2%,12150.0,5.0,17.0,15.0,22.0,AXGN
312,M,2014-06-04 15:53:39,2014-06-02,AXGN,Freitag Gregory Gene,CFO,P - Purchase,2.45,5200,29518,+21%,12718.0,5.0,17.0,15.0,22.0,AXGN
313,,2014-05-22 17:56:32,2014-05-20,AXGN,Schiaparelli Jill F,"SVP, Bus. Strategy, Marketing",P - Purchase,2.63,2000,12750,+19%,5260.0,-1.0,-3.0,10.0,4.0,AXGN
314,,2014-05-13 10:55:43,2014-05-12,AXGN,Zaderej Karen L.,CEO,P - Purchase,2.7,5000,329056,+2%,13500.0,-1.0,0.0,5.0,7.0,AXGN
315,D,2014-05-12 12:33:56,2014-05-05,AXGN,Mandato Joseph M,Dir,A - Grant,2.64,15000,30000,+100%,39600.0,0.0,-2.0,0.0,4.0,AXGN
316,M,2014-05-08 17:20:58,2014-05-06,AXGN,Gold Mark Stephen,Dir,P - Purchase,2.6,1977,271971,+1%,5140.0,10.0,4.0,2.0,7.0,AXGN
317,D,2014-04-28 17:35:46,2014-04-25,AXGN,Gold Mark Stephen,Dir,M - OptEx,2.02,17007,269994,+7%,34352.0,-3.0,-6.0,-5.0,-3.0,AXGN
318,D,2014-03-17 19:34:56,2014-03-14,AXGN,Zaderej Karen L.,CEO,M - OptEx,0.27,72348,209222,+53%,19534.0,5.0,6.0,-9.0,-24.0,AXGN
319,D,2014-03-17 19:34:56,2014-03-13,AXGN,Zaderej Karen L.,CEO,P - Purchase,3.49,1500,209222,+1%,5233.0,5.0,6.0,-9.0,-24.0,AXGN
320,D,2014-01-06 15:01:12,2014-01-02,AXGN,Freitag Gregory Gene,CFO,A - Grant,0.0,6250,38901,+19%,0.0,-1.0,-12.0,-14.0,-47.0,AXGN
321,D,2014-01-06 14:52:35,2014-01-02,AXGN,Zaderej Karen L.,CEO,A - Grant,0.0,6250,135374,+5%,0.0,-1.0,-12.0,-14.0,-47.0,AXGN
322,D,2013-11-19 14:43:17,2013-11-19,AXGN,Gold Mark Stephen,Dir,M - OptEx,1.07,290,252987,0%,311.0,0.0,-2.0,-12.0,-37.0,AXGN
323,M,2013-08-30 13:47:51,2013-08-28,AXGN,McCarrey Shawn F,SVP of Sales,P - Purchase,3.21,25000,30000,+500%,80151.0,1.0,9.0,38.0,27.0,AXGN
324,,2013-08-27 13:24:44,2013-08-24,AXGN,McCarrey Shawn F,SVP of Sales,P - Purchase,3.0,5000,5000,New,15000.0,-2.0,-3.0,38.0,24.0,AXGN
325,M,2013-08-20 18:19:49,2013-08-16,AXGN,Mandato Joseph M,Dir,A - Grant,3.0,15000,1441392,+1%,44950.0,0.0,9.0,47.0,39.0,AXGN
326,,2013-08-16 14:48:47,2013-08-14,AXGN,Schiaparelli Jill F,"SVP, Bus. Strategy, Marketing",P - Purchase,3.0,5000,10750,+87%,15000.0,0.0,2.0,44.0,46.0,AXGN
327,,2013-08-15 15:45:59,2013-08-14,AXGN,Harper John Frederick,Dir,P - Purchase,3.0,66666,214094,+45%,199998.0,0.0,1.0,51.0,44.0,AXGN
328,,2013-08-15 15:18:43,2013-08-14,AXGN,Zaderej Karen L.,CEO,P - Purchase,3.0,8334,129124,+7%,25002.0,0.0,1.0,51.0,44.0,AXGN
329,,2013-08-15 15:07:20,2013-08-14,AXGN,Freitag Gregory Gene,CFO,P - Purchase,3.0,8334,32652,+34%,25002.0,0.0,1.0,51.0,44.0,AXGN
330,D,2013-04-10 16:34:15,2012-10-01,AXGN,Harper John Frederick,Dir,P - Purchase,3.61,86557,147428,+142%,312471.0,0.0,23.0,15.0,10.0,AXGN
331,DM,2013-02-28 14:32:09,2012-05-10,AXGN,Gold Mark Stephen,Dir,M - OptEx,0.29,14029,19484,+257%,4020.0,0.0,-4.0,-9.0,-19.0,AXGN
332,,2012-12-13 13:25:48,2012-12-10,AXGN,Zaderej Karen L.,CEO,P - Purchase,2.5,900,120790,+1%,2250.0,2.0,-4.0,46.0,72.0,AXGN
333,,2012-12-06 08:20:36,2012-12-04,AXGN,Schiaparelli Jill F,"SVP, Bus. Strategy, Marketing",P - Purchase,2.55,2000,5750,+53%,5100.0,0.0,-4.0,29.0,77.0,AXGN
334,,2012-12-03 16:08:38,2012-11-29,AXGN,Schiaparelli Jill F,"SVP, Bus. Strategy, Marketing",P - Purchase,2.7,1000,3750,+36%,2700.0,11.0,13.0,19.0,87.0,AXGN
335,,2012-11-23 09:18:17,2012-11-20,AXGN,Zaderej Karen L.,CEO,P - Purchase,2.69,100,119890,0%,269.0,0.0,0.0,-9.0,67.0,AXGN
336,M,2012-11-16 15:26:49,2012-11-14,AXGN,Schiaparelli Jill F,"SVP, Bus. Strategy, Marketing",P - Purchase,2.56,2750,1000,-157%,7035.0,8.0,10.0,-4.0,82.0,AXGN
337,AD,2012-02-13 14:14:35,2011-10-10,AXGN,Mandato Joseph M,Dir,A - Grant,2.75,5455,1431847,0%,15001.0,1.0,-1.0,1.0,-4.0,AXGN
338,D,2012-01-24 16:08:20,2011-12-23,AXGN,Friedman Mark Louis,"VP of RA, QA",M - OptEx,0.27,5665,5665,New,1530.0,7.0,0.0,-13.0,-13.0,AXGN
339,,2012-01-03 15:50:40,2011-12-30,AXGN,Rudelius Robert James,Dir,A - Grant,2.4,9318,23273,+67%,22363.0,-4.0,6.0,15.0,19.0,AXGN
340,,2012-01-03 15:49:53,2011-12-30,AXGN,Freitag Gregory Gene,CFO,P - Purchase,2.4,9318,24318,+62%,22363.0,-4.0,6.0,15.0,19.0,AXGN
341,D,2011-12-21 20:18:59,2011-12-19,AXGN,Zaderej Karen L.,CEO,M - OptEx,0.27,76741,119790,+178%,20720.0,-4.0,-4.0,24.0,24.0,AXGN
342,M,2011-12-06 07:51:55,2011-11-01,AXGN,Rudelius Robert James,Dir,P - Purchase,2.72,8500,13955,+156%,23125.0,-3.0,6.0,2.0,24.0,AXGN
343,M,2011-11-23 14:36:16,2011-11-21,AXGN,Freitag Gregory Gene,CFO,P - Purchase,2.91,15000,15000,New,43645.0,0.0,4.0,-13.0,23.0,AXGN
344,D,2011-10-12 17:35:25,2011-10-10,LECT,Grooms Jamie Mark,Dir,A - Grant,2.75,5455,351417,+2%,15001.0,,,,,AXGN
345,D,2011-10-12 17:33:34,2011-10-10,LECT,Rudelius Robert James,Dir,A - Grant,2.75,5455,5455,New,15001.0,,,,,AXGN
346,D,2011-10-12 17:31:32,2011-10-10,LECT,Harper John Frederick,Dir,A - Grant,2.75,5455,51553,+12%,15001.0,,,,,AXGN
347,D,2011-10-12 17:27:50,2011-10-10,LECT,Mandato Joseph M,Dir,A - Grant,2.75,5455,1431847,0%,15001.0,,,,,AXGN
348,D,2011-10-12 17:25:32,2011-10-10,LECT,Gold Mark Stephen,Dir,A - Grant,2.75,5455,381681,+1%,15001.0,,,,,AXGN
349,,2011-09-28 17:29:30,2011-09-28,LECT,Hopfenspirger Larry,10%,P - Purchase,1.81,20000,459325,+5%,36200.0,,,,,AXGN
